Prehospital hypoxia, hypotension, and hypocarbia each were associated with poor outcomes after traumatic brain injury, ...

The finding may open a whole new world in the study of Alzheimer's disease, said biophysicist Aneta Stefanovska.

These boards are cropping up around the US as neurologists acclimate to a new class of drugs, but not everyone agrees such ...

A paradigm-shifting study from the Centre for Addiction and Mental Health (CAMH) shows an experimental drug, GL-II-73, has ...

The findings suggest that mild or moderate Covid-19 may accelerate biological processes that contribute to the buildup of ...

The Washington University trial comes as part of a larger platform study which hopes to understand if Alzheimer's disease can ...

For years, scientists have focused on amyloid beta buildup as the main culprit in Alzheimer’s disease, but a new study suggests the real problem might lie in a stalled protein-cutting process in the ...

COVID-19, even in mild cases, is linked to changes in Alzheimer’s disease-related brain biomarkers comparable to four years ...

The tiny protein known as transthyretin can cause big problems in the body when it misfolds after secretion. While healthy ...

An international trial is testing remternetug in young adults at genetic risk for early-onset Alzheimer’s. The study aims to ...